Yili Kevin Xie - Jul 27, 2022 Form 4 Insider Report for HUMANIGEN, INC (HGEN)

Role
Director
Signature
/s/ Timothy E. Morris, Attorney-in-Fact
Stock symbol
HGEN
Transactions as of
Jul 27, 2022
Transactions value $
$0
Form type
4
Date filed
7/29/2022, 06:30 PM
Previous filing
Jan 5, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HGEN Stock Option (Right to Buy) Award $0 +83.4K $0.00 83.4K Jul 27, 2022 Common Stock 83.4K $0.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in two equal installments on the first and second anniversaries of the grant date.